Yates Nathanael James
Rev Neurosci. 2016 Oct 1;27(7):669-687. doi: 10.1515/revneuro-2016-0030.
Schizophrenia has long been associated with abnormalities in circadian rhythms and sleep. Up until now, there have been no thorough reviews of the potential mechanisms behind the myriad of circadian and sleep abnormalities observed in schizophrenia and psychosis. We present evidence of sleep playing an important role in psychosis predominantly mediated by dopaminergic pathways. A synthesis of both human and animal experimental work suggests that the interplay between sleep and dopamine is important in the generation and maintenance of psychosis. In particular, both animal and human data point to sleep disruption increasing dopamine release and sensitivity. Furthermore, elevated dopamine levels disrupt sleep and circadian rhythms. The synthesis of knowledge suggests that circadian rhythms, dopamine dysregulation, and psychosis are intricately linked. This suggests that treatment of circadian disturbance may be a useful target in improving the lives and symptoms of patients with schizophrenia.
长期以来,精神分裂症一直与昼夜节律和睡眠异常有关。到目前为止,尚未对精神分裂症和精神病中观察到的众多昼夜节律和睡眠异常背后的潜在机制进行全面综述。我们提供证据表明,睡眠在精神病中起重要作用,主要由多巴胺能通路介导。对人类和动物实验研究的综合分析表明,睡眠与多巴胺之间的相互作用在精神病的发生和维持中很重要。特别是,动物和人类数据均表明睡眠中断会增加多巴胺释放和敏感性。此外,多巴胺水平升高会扰乱睡眠和昼夜节律。知识的综合表明,昼夜节律、多巴胺失调和精神病之间存在复杂的联系。这表明治疗昼夜节律紊乱可能是改善精神分裂症患者生活和症状的一个有用靶点。